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A BS T R AC T
BACKGROUND

Environmental enteric dysfunction (EED) is an enigmatic disorder of the small
intestine that is postulated to play a role in childhood undernutrition, a pressing
global health problem. Defining the incidence of this disorder, its pathophysiological features, and its contribution to impaired linear and ponderal growth has
been hampered by the difficulty in directly sampling the small intestinal mucosa
and microbial community (microbiota).
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METHODS

Mr. Chen and Dr. Kung, and Drs. Ahmed
and Gordon, contributed equally to this
article.

In this study, among 110 young children (mean age, 18 months) with linear
growth stunting who were living in an urban slum in Dhaka, Bangladesh, and had
not benefited from a nutritional intervention, we performed endoscopy in 80 children who had biopsy-confirmed EED and available plasma and duodenal samples.
We quantified the levels of 4077 plasma proteins and 2619 proteins in duodenal
biopsy samples obtained from these children. The levels of bacterial strains in
microbiota recovered from duodenal aspirate from each child were determined
with the use of culture-independent methods. In addition, we obtained 21 plasma
samples and 27 fecal samples from age-matched healthy children living in the
same area. Young germ-free mice that had been fed a Bangladeshi diet were colonized with bacterial strains cultured from the duodenal aspirates.
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RESULTS

Of the bacterial strains that were obtained from the children, the absolute levels
of a shared group of 14 taxa (which are not typically classified as enteropathogens)
were negatively correlated with linear growth (length-for-age z score, r = −0.49;
P = 0.003) and positively correlated with duodenal proteins involved in immunoinflammatory responses. The representation of these 14 duodenal taxa in fecal microbiota was significantly different from that in samples obtained from healthy
children (P<0.001 by permutational multivariate analysis of variance). Enteropathy
of the small intestine developed in gnotobiotic mice that had been colonized with
cultured duodenal strains obtained from children with EED.
CONCLUSIONS

These results provide support for a causal relationship between growth stunting
and components of the small intestinal microbiota and enteropathy and offer a
rationale for developing therapies that target these microbial contributions to EED.
(Funded by the Bill and Melinda Gates Foundation and others; ClinicalTrials.gov
number, NCT02812615.)
n engl j med 383;4
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nvironmental enteric dysfunction
(EED) is a disease of the small intestine
for which the causative factors are poorly
understood. The condition was first described in
the 1960s by pathologists who were examining
biopsy samples obtained from the proximal small
bowel of adult Peace Corps volunteers who had
lived in areas with high levels of fecal–oral contamination and in whom diarrhea and intestinal malabsorption developed.1 Histopathological
changes included diminution in the number and
height of intestinal villi with associated loss of
absorptive surface area, disruption of the epithelial barrier, and a chronic inflammatory infiltrate.
Several studies have documented an association between altered absorptive function of the
small intestine (as defined by dual-sugar permeability tests) and both asymptomatic infection
with one or more enteropathogens and growth
stunting.2,3 Stunting is associated with poor developmental outcomes, including reduced intellectual capacity and an impaired response to oral
vaccines.4-7 Despite considerable effort, neither nutritional interventions nor initiatives to improve
water quality, sanitation, and hygiene practices
have proved to be effective in reducing the incidence of stunting.8,9 These results support the
hypothesis that subclinical enteric dysfunction
contributes to stunting.10
Most studies of EED have relied on nonvalidated fecal or plasma biomarkers because esophagogastroduodenoscopy (EGD) is rarely performed in undernourished pediatric populations
to obtain duodenal biopsy samples because of its
inherent risks. Consequently, there are conflicting data about the incidence of EED and its relationship to stunting.11 Evidence that perturbed
development of the microbiota contributes to
undernutrition is provided by studies involving
the analysis of fecal samples,12-14 and recent data
suggest a potential role for bacteria in the upper
gastrointestinal tract.15
To examine the role of the duodenal microbiota in the pathogenesis of EED and its relationship to stunting, we initiated the Bangladesh
Environmental Enteric Dysfunction (BEED) study
involving young children who live in an urban
slum (Mirpur) in Dhaka.16 This study has two
components: an interventional phase, which was
designed to test whether a nutritional interven-
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tion administered for 3 months would improve
linear growth in children between the ages of 12
and 18 months who were stunted or at risk for
stunting,17 and a diagnostic phase involving children who did not have a response to the nutritional intervention and who subsequently underwent EGD with duodenal biopsy. The results of
the diagnostic phase of the study are reported here.

Me thods
Study Design and Oversight

The BEED study was approved by the ethical review committee at the International Centre for
Diarrhoeal Disease Research, Bangladesh. Written informed consent was obtained from each
child’s parent or guardian to participate in the
study and to undergo EGD if the child met the
criteria for being stunted or at risk for stunting.
Children who had a length-for-age z score greater
than 2 standard deviations below that of children in a healthy reference cohort of the World
Health Organization (i.e., length-for-age z score,
less than −2) were classified as stunted, and those
with a score between −2 and −1 were classified
as being at risk for stunting. For 3 months, children in the two groups received one large egg
(weight, 60 to 65 g), 150 ml of cow’s milk, and
multiple micronutrients for 6 days per week, plus
an anthelmintic medication.16 A lack of response
to the nutritional intervention was defined as
continuing to have a z score of less than −2 in
the stunted group and a score of between −1 and
−2 in the at-risk group. All the children who did
not have a response to the nutritional intervention and who did not have a coexisting illness
that causes undernutrition16 were deemed to be
qualified to undergo EGD. At the time of the
EGD procedure, we obtained plasma, fecal samples, and duodenal aspirates and biopsy samples
(Tables S1 and S2 in Supplementary Appendix 2,
available with the full text of this article at
NEJM.org). In addition, we obtained 21 plasma
samples and 27 fecal samples from age-matched
healthy children (who were defined as having a
z score of −1 or more for both weight-for-length
and length-for-age measures) living in Mirpur.
None of the children undergoing EGD received
antibiotics for at least 2 weeks before the procedure.
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Proteomic Assays

We performed proteomic assays (SOMAScan,
SomaLogic) to quantify several thousand proteins spanning a broad range of biologic functions.18 In this study, we analyzed 4077 plasma
proteins and 2619 duodenal proteins that passed
quality-control filtering. Details about these
analyses are provided in the Methods section in
Supplementary Appendix 1.
DNA Sequencing and Enteropathogen
Detection

We analyzed bacterial taxa present in duodenal
aspirates and fecal samples by sequencing amplicons that were generated from variable region
4 of bacterial 16S ribosomal DNA (rDNA) genes
using a polymerase-chain-reaction (PCR) assay.
We grouped V4-16S rDNA reads into amplicon
sequence variants (i.e., sequences in which artifacts generated by sequencing errors have been
removed) and then normalized their levels using
DESeq2.19 The levels of amplicon sequence variants were then scaled according to bacterial load
and were log10-transformed before the performance of additional analyses. A PCR-based assay
was used to quantify duodenal and fecal levels
of 18 bacterial, viral, and protozoan enteropathogens.20
Analysis in Gnotobiotic Mice

In these experiments, which were approved by
the Washington University animal studies committee, 5.5-week-old, male, germ-free C57BL/6J
mice were fed a diet representative of that consumed by 18-month-old children living in Mirpur. (Details regarding the composition of the
typical diet are provided in Table S9 in Supplementary Appendix 2.) A collection of 39 bacterial strains cultured from duodenal samples
obtained from the study children who had histopathological evidence of EED was then administered to the mice by oral gavage. Age-matched
mice with the same genetic background (C57BL/6J)
that had also been raised under sterile conditions and fed the same diet received the cecal
microbiota of a conventionally raised C57BL/6J
mouse by gavage; these animals served as conventionalized controls. After the mice had been
euthanized, we extracted DNA from luminal
contents obtained from different regions of the
intestines and determined the levels of bacterial

n engl j med 383;4

strains. Details are provided in the Methods section in Supplementary Appendix 1. In addition,
we performed gene-expression analysis, immunoassays, and histologic analysis to characterize
duodenal tissue.
Statistical Analysis

We determined the strength of the association
between the presence of EED and duodenal protein modules, levels of plasma proteins, levels of
duodenal amplicon sequence variants, the histopathological severity score, and length-for-age
z score according to the Pearson correlation co
efficient. Spearman’s rank correlation was used
to identify relationships between the length-forage z score and the enteropathogen burden.
Relationships between the duodenal proteome and
absolute levels of duodenal amplicon sequence
variants were assessed by means of singular
value decomposition of a cross-covariance matrix. Reported P values have not been adjusted
for multiple comparisons; a P value of less than
0.05 was considered to indicate statistical significance for analyses that did not require correction for multiple hypothesis testing. Q values
were adjusted for the false discovery rate21; a
value of less than 0.1 was considered to indicate
statistical significance. Point estimates and dispersion are reported as means and 95% confidence intervals unless otherwise indicated.

R e sult s
Study Patients

From July 2016 through July 2018, we enrolled
525 children in our study. Of these enrollees,
110 children (mean [±SD] age, 18±2 months)
who did not have a response to the nutritional
intervention underwent EGD. During the nutritional intervention, these children had not shown
significant improvement in linear growth (mean
change from baseline in the length-for-age z score,
0.03; 95% confidence interval [CI], −0.03 to 0.08;
P = 0.40), although they had shown significant
improvement in the weight-for-age z score
(change from baseline, 0.15; 95% CI, 0.08 to
0.22; P<0.001) (Table S1 in Supplementary Appendix 2).
We determined the severity of EED according
to histologic analysis of duodenal biopsy samples obtained from the children. Included in the
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Table 1. Clinical Characteristics of the Study Children, According to Subgroup.*
No Benefit from Nutritional
Intervention
(N = 110)

Biopsy-Confirmed EED
with Available Plasma
and Duodenal Samples
(N = 80)

Age — mo

18.4±2.1

18.3±2.1

Female sex — no. (%)

64 (58)

48 (60)

Length-for-age z score

−2.19±0.82

−2.29±0.86

Weight-for-age z score

−1.76±0.87

−1.85±0.91

Weight-for-length z score

−0.96±0.91

−1.02±0.93

6 (5)

0

Characteristic
Demographic

Anthropometric findings at the time of endoscopy

Histopathological score for EED on duodenal bi‑
opsy sample — no. (%)
No evidence
Mild

41 (37)

34 (42)

Moderate

13 (12)

10 (12)

Severe

50 (45)

36 (45)

Median fecal biomarker levels (IQR)
Alpha-1 antitrypsin — mg/g

0.33 (0.17–0.50)

0.33 (0.17–0.50)

Myeloperoxidase — ng/ml

2325.5 (799.6–4569.1)

2006.0 (809.9–4315.0)

Neopterin — nmol/liter

1116.5 (495.5–2552.5)

1146.0 (506.3–2575.3)

EED biomarker score†

2.60 (1.52–4.25)

2.77 (1.52–4.24)

*	Plus–minus values are means ±SD. To convert the values for alpha-1 antitrypsin to grams per liter, multiply by 0.01.
Percentages may not total 100 because of rounding. IQR denotes interquartile range, and NA not applicable.
†	The biomarker score for environmental enteric dysfunction (EED) is a continuous measurement starting at 0, with higher
scores indicating greater levels of a group of fecal biomarkers of inflammation (alpha-1 antitrypsin, myeloperoxidase,
and neopterin).

composite scoring system was the presence of
infiltrating immune cells, villus atrophy, and
crypt hyperplasia (Table 1 and Fig. S1 in Supplementary Appendix 1, where all the supplementary figures in this article are provided). Biopsy
samples were graded on a scale of 0 to 3, in
which grade 0 indicated normal histologic features (in 6 children), grade 1 mild histopathological changes (in 41 children), grade 2 moderate abnormalities (in 13 children), and grade 3
severe abnormalities (in 50 children). According
to this definition, there was no significant correlation between the length-for-age z score and
either the histopathological severity score (P = 0.57)
or an EED biomarker score that is based on fecal
levels of three markers of intestinal inflammation and barrier disruption (myeloperoxidase,
alpha-1 antitrypsin, and neopterin) (P = 0.36)
(Table 2).
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Matched sets of plasma samples and duodenal biopsy samples were collected from 84 of the
110 children. Of these biopsy samples, 4 had
normal histologic features, which left 80 children with matched samples for analysis (Table 1
and Tables S1 and S2 in Supplementary Appendix 2). There was sufficient fluid in the duodenal
lumen of 38 of these 84 children to obtain an
aspirate for analysis of the microbial community
content; of the 38 children with sufficient fluid,
2 had normal biopsy samples (Fig. S2).
Plasma Proteomes in Affected Children

Because biopsy samples were not obtained before the nutritional intervention, we could not
confirm whether EED was present at the time of
enrollment. In addition, only four children who
had normal biopsy samples also had available
plasma samples, and a single normal finding on
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−0.06

Histopathological severity score**

−0.06 (−0.27 to 0.15)

−0.07 (−0.23 to 0.08)

0.09 (−0.07 to 0.24)

−0.13 (−0.29 to 0.08)

−0.19 (−0.31 to 0.00)

−0.38 (−0.61 to −0.15)

−0.32 (−0.56 to −0.08)

0.57

0.36

0.27

0.11

0.05

0.003

0.01

0.007

0.006

0.02

P Value

—

—

—

—

—

0.04

0.10

0.06

0.06

0.10

Q Value‡

—

—

—

—

—

38.9 (34.1 to 43.8)¶

33.0 (2.67 to 63.3)¶

0.79 (0.57 to 1.00)

2.37 (1.30 to 3.43)

45.2 (38.3 to 52.2)

percent

Mean Relative Level
(95% CI)

*	Shown are data for two subgroups of study children with EED: the 36 children who had an available aspirate sample that was analyzed by means of a sequence-based, culture-inde‑
pendent method, for whom duodenal microbiota data are presented; and the 110 children who had no response to the nutritional intervention and were eligible for endoscopy, for
whom data regarding fecal biomarkers and histopathological severity are presented. The dashed lines indicate that the determination of Q values and mean relative levels is not ap‑
plicable because multiple comparisons were not performed and because these measurements were calculated on an absolute scale.
†	Values for the total bacterial load and levels of duodenal bacterial taxa were log-transformed and z-scored before determining their relationships with the length-for-age z score. Thus,
in this category, coefficients represent the effect of a unit change in the standard deviation of the bacterial load or the absolute levels of bacterial taxa on the length-for-age z score.
‡	Q values are P values that have been adjusted for the false discovery rate.
§	The total bacterial load represents the inverse of the fractional level of the Alicyclobacillus acidiphilus spike-in.
¶	Absolute values rather than percentages are reported for all bacterial loads. Absolute levels were defined as the inverse of the relative levels of a spiked-in bacterial strain not typically
found in the human gut microbiota (A. acidiphilus).
‖	The total bacterial load of core group taxa represents the total of the absolute levels of the 14 bacterial amplicon sequence variants found in more than 80% of duodenal aspirates at a
relative level of more than 0.01%.
**	The histopathological severity score ranges from 0 to 3, with higher scores indicating more severe histopathological abnormalities.

0.11
−0.09

EED biomarker score

−0.15

Alpha-1 antitrypsin

Neopterin

−0.19

Myeloperoxidase

Correlation between length-for-age z score
and fecal biomarkers and histopathological
severity

−0.41

All bacteria§
110

−0.44

Veillonella sp.

−0.32 (−0.54 to −0.10)

−0.31 (−0.53 to −0.10)

Total bacterial load

−0.31 (−0.54 to −0.07)

−0.45

Coefficient
(95% CI)†

−0.40

Pearson Correlation
Coefficient

Rothia mucilaginosa

36

no.

Children
in Subgroup

Streptococcus sp.

Correlation between length-for-age z score
and features of duodenal microbiota

Variable

Table 2. Correlations between Length-for-Age z Scores and Features of Duodenal Microbiota, Fecal Biomarkers, and Histopathological Severity among Children with EED.*
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biopsy does not rule out the possibility of disease at another duodenal site. All these considerations led us to focus our analysis on post
intervention plasma samples obtained from
children with a histopathological diagnosis of
EED. Among the five plasma proteins with levels
that most strongly correlated with the length-forage z score, four proteins — insulin-like growth
factor 1 (IGF-1), IGF acid-labile subunit (IGFALS),
IGF binding protein 3 (IGFBP-3), and procollagen C endopeptidase enhancer 2 (PCOLCE2)
— were positively correlated, whereas IGFBP-2
was negatively correlated (Table S3A in Supplementary Appendix 2). Two of these proteins,
IGFALS and IGFBP-3, stabilize IGF-1, which increases its half-life and bioavailability. Consistent with this finding is our observation that
IGFBP-2, a protein that sequesters and inhibits the
growth-potentiating functions of IGF-1, was negatively correlated with the length-for-age z score.22
PCOLCE2 cleaves the C-terminal propeptide of
type I procollagen and is thought to facilitate
bone formation, which is consistent with our
observation of the positive correlation between
this protein and the length-for-age z score.23
We created a linear model to examine the
relationship between IGF-1 and the length-forage z score and the effect (interaction) of other
members of the plasma proteome on this relationship (see the Methods section in Supplementary Appendix 1). Of the 4076 proteins tested for
association with IGF-1 levels as related to the
z score, osteoprotegerin (OPG or TNFRSF11B), a
decoy receptor for receptor activator of nuclear
factor-κB (RANK) ligand, which promotes bone
growth by inhibiting osteoclastic activity,24 ranked
fourth (beta = 0.22±0.08; unadjusted P = 0.005),
and phosphate-regulating neutral endopeptidase
(PHEX), the product of the gene responsible for
X-linked hypophosphatemia and hereditary rickets,25 ranked sixth (beta = 0.25±0.08; unadjusted
P = 0.004) (Table S4 in Supplementary Appendix 2).
Comparisons of the plasma proteomes of the 80
children with EED and 21 age-matched healthy
children before and after the nutritional intervention are provided in Figure S3 and Table S5A
through 5F in Supplementary Appendix 2.

had an available aspirate sample. (For ethical
reasons, duodenal specimens were not obtained
from healthy children living in Mirpur.) Shotgun
sequencing of aspirate DNA revealed that bacteria dominated the microbial community (Table 1
in Supplementary Appendix 3). Sequencing analysis of V4-16S rDNA revealed 165 distinct amplicon sequence variants (taxa) with relative levels
of at least 0.01% in 1 or more of the 36 samples.
A core group of 14 bacterial taxa were present in
at least 80% of the aspirates obtained from children with EED (Table S6A in Supplementary
Appendix 2). Permutational multivariate analysis
of variance revealed no significant effects of
breast-feeding status on duodenal bacterial composition before, during, or after the nutritional
intervention.
We used an additional duodenal biopsy sample that had been obtained from each of the 80
children and had not been used for histopathological analysis to quantify expressed proteins.
Our goal was to obtain a mechanistic definition
of enteropathy that was more comprehensive than
that provided by a tissue section stained with
hematoxylin and eosin. We reasoned that such a
definition could serve as a starting point for
identifying features in the duodenal habitat that
might correlate with the composition of the duodenal microbiota and the length-for-age z score.
We performed independent components analysis
(ICA), a method that is used to identify modules
of coexpressed genes that belong to distinct biologic pathways,26,27 to search for groups of duodenal proteins that are involved in inflammation,
injury, and metabolic dysfunction and thus could
underlie the enteropathy observed in these children. Our analysis of 2619 proteins in the 80
duodenal proteomic data sets resulted in the
grouping of 901 proteins into 14 modules containing between 63 and 183 proteins. The “biologic process” terms, as defined in the Gene
Ontology project, that were most represented in
each module are provided in Table 2A through
2N in Supplementary Appendix 3. Module 1 contained proteins enriched in Gene Ontology terms
related to neutrophil activation, acute inflammation, and host immune responses against pathogens (Table S7A and S7B in Supplementary ApDuodenal Microbiota and Proteome Analyses pendix 2).
We characterized the composition of the duodeWe performed singular value decomposition
nal microbiota in the 36 children with EED who of the cross-correlation matrix between levels of
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duodenal proteins and absolute levels of core
group bacterial taxa to determine whether features of the duodenal proteome and duodenal
microbiota were significantly correlated.28 Figure
S4 shows the 50 proteins with the most significant positive correlations and the 50 having the
most significant negative correlations with the
absolute levels of these core taxa. Of these 100
proteins, 22 were members of ICA Module 1
(hypergeometric test of enrichment, P<0.001).
Figure 1A and 1B summarize the top 10 positive
correlations, including two antimicrobial peptides (cathelicidin antimicrobial peptide [CAMP]
and chitinase-3-like protein 1 [CHI3L1]), plus an
established fecal biomarker of intestinal inflammation, lipocalin-2 (LCN2). In addition, there was
a negative correlation between the levels of these
core taxa and the levels of 10 proteins produced by
absorptive enterocytes (e.g., cadherin-related family member 5 [CDHR5], which is required for
brush border formation)29 (Fig. S4A and S4B).
There was a significantly negative correlation
between the length-for-age z score and both the
total bacterial load in the duodenum (the sum of
the absolute levels of all organisms) and the
absolute levels of 13 of the 14 core group taxa,
including the 3 organisms that were most
strongly correlated with duodenal inflammatory
proteins in Module 1: a veillonella species, a
streptococcus species, and Rothia mucilaginosa
(Q<0.10 after adjustment for false discovery rate)
(Fig. 1C through 1F, Table 2, and Table S6B in
Supplementary Appendix 2). (Details regarding
duodenal proteins that were correlated with the
length-for-age z score are provided in Table S3B
in Supplementary Appendix 2.) Neither the total
bacterial load nor the levels of any of these 13
taxa were significantly correlated with the severity of the histopathological features. PCR assays
of 18 enteropathogens that are commonly observed in the study population20 showed no significant correlation between their levels in duodenal aspirates and the length-for-age z score
(P>0.10 by Spearman’s correlation) (Table S8A in
Supplementary Appendix 2).
We expanded our analysis to include plasma
samples and duodenal biopsy samples obtained
from the 44 children from whom we could not
obtain duodenal aspirates (i.e., for a total of 80
children) (Fig. S1). We correlated the levels of
plasma proteins with the levels of 100 duodenal

n engl j med 383;4

proteins that were most positively or negatively
associated with the 14 core taxa (50 duodenal
proteins in each direction). Plasma levels of regenerating family member 3 alpha (REG3A) had
the strongest correlation (P = 6.9×10−6; Q = 0.03),
followed by LCN2 (Q = 0.09) and 6-pyruvoyl tetrahydropterin synthase (PTS) (Q = 0.10), an enzyme
involved in the production of tetrahydrobiopterin (BH4, also called sapropterin), a cofactor for
several enzymes including those involved in the
production of nitric oxide and several neuro
transmitters. A summary of positive correlations
between plasma levels of REG3A and the core
taxa–associated duodenal proteins is provided in
Figure 1G; the strongest correlation was with
LCN2 expressed in the duodenum. (LCN2 is also
expressed in other tissues, including the esophageal mucosa and minor salivary glands.) (Details
regarding duodenal proteins that were correlated with plasma levels of PTS and LCN2 are
provided in Figure S5).
In a comparison of levels of each of the 14
duodenal core taxa in fecal samples obtained
from 27 healthy children and 48 children with
EED, there was a significantly elevated level of
veillonella species, the bacterium that was most
positively correlated with proteins involved in duodenal inflammation in samples obtained from
the children with EED (P = 0.001; Q = 0.01). This
organism has also been associated with stunting
in a study involving children living in Madagascar and the Central African Republic.15 An even
greater difference could be appreciated when all
14 taxa were considered together (P<0.001 by
permutational multivariate analysis of variance)
(Fig. S6). In children with EED and in healthy
children, the most frequently detected pathogens in the fecal microbiota were Escherichia coli
strains (EPEC, ETEC, and EAEC), along with
giardia and campylobacter species. Although
there were no significant between-group differences in the levels of any one enteropathogen
(P>0.05 by Mann–Whitney U test), a significant
ly greater diversity in pathogens was detected in
children with EED than in healthy controls
(mean number of unique pathogens, 4.6±2.0 vs.
2.7±1.4; P = 0.002 by Mann–Whitney U test) (Table S8B in Supplementary Appendix 2). Among the
children with EED, there was no significant correlation between the length-for-age z score and
either the number of different pathogens de-
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Figure 1 (facing page). Correlations between Components
of the Duodenal Proteome, the Absolute Levels
of Duodenal Bacterial Taxa, and Stunting.
Panel A shows the top 10 positive correlations between
members of the 14 core taxa among the study children
with environmental enteric dysfunction (EED) and duo‑
denal proteins. A larger size and darker color of the cir‑
cle represent a greater magnitude of the correlation.
Negative correlations were included to match the color
bar in Figure S4 in Supplementary Appendix 1. Panel B
shows annotations of proteins that are indicated in
Panels A and G. Panels C through F show the total duo‑
denal bacterial load and levels of the three organisms
that were most positively correlated with duodenal in‑
flammatory proteins and that had a significantly nega‑
tive correlation with the length-for-age z score (LAZ).
A spike-in is a known amount of a bacterium that is not
typically found in the human gut microbiota (Alicyclobacillus acidiphilus). The spike-in is added to each duo‑
denal aspirate sample to determine the absolute levels
of each bacterium as well as the total density of bacte‑
ria per volume of aspirate (i.e., the bacterial load). Ab‑
solute levels are calculated by normalizing the levels of
each bacterium to the levels of the spike-in organism.
The least-squares regression line is depicted in blue,
and shaded regions denote 95% confidence intervals.
The letter r indicates the Pearson correlation coeffi‑
cient. Panel G shows a star network of correlations be‑
tween plasma levels of REG3A (regenerating family
member 3 alpha), a secretory protein that has been as‑
sociated with cell proliferation or differentiation and
that had the strongest correlation with the 14 core taxa,
and each of the core taxa–associated duodenal proteins.
As indicated by the color key, darker-colored lines con‑
necting REG3A to the various proteins indicate a stron‑
ger correlation. The duodenal protein with the stron‑
gest correlation, lipocalin-2 (LCN2), is indicated by the
tail of the arrow line at the 3 o’clock position; duodenal
proteins with progressively weaker correlations with
REG3A are distributed in a counterclockwise manner
from this position.

tected in feces or the level of any single pathogen (Q>0.05 by Spearman’s correlation).
Transmission of Enteropathy to Mice

After identifying an association between a
shared group of bacterial taxa that were present
in the duodenal microbiota of children with EED
and a proteomic signature of duodenal inflammation and growth stunting, we evaluated
whether these taxa were causally related to the
pathogenesis of this enteropathy when modeled
in a mouse. We first cultured 39 bacterial strains
from duodenal aspirates, including 11 of the 14
core group taxa. (Functional annotations of the
genomes of these taxa are provided in Figure S7
and also in Table 3 in Supplementary Appendix 3.)
n engl j med 383;4

This collection of microbes (EED collection) was
administered by oral gavage to one group of
mice; the control mice received cecal microbiota
from a conventionally raised mouse (Fig. 2A).
Both groups of mice were fed an animal-protein–
deficient diet representing the typical diet of
18-month-old children living in Mirpur (Table
S9). We detected 23 of the 39 bacterial strains at
a mean relative level of more than 0.01% at one
or more locations along the gastrointestinal tract
in mice that received the EED collection (Fig. 2B,
Fig. S8, and Table S10 in Supplementary Appendix 2). Of these 23 strains, 9 corresponded to
core duodenal bacterial amplicon sequence variants (including the veillonella species) that had a
negative correlation with length-for-age z scores.
Unlike the control mice, the mice that received the EED collection had an inflammatory
infiltrate in the lamina propria of the small intestine that was dominated by mononuclear cells
(including lymphocytes), with associated disruption of the overlying epithelium and sloughing
of epithelial cells from the upper portion of villi
(Fig. 2C, 2D, and 2E). Crypt elongation, a regenerative response to epithelial damage, was the
most consistent feature of architectural distortion (Fig. 2F). These histopathological changes
occurred in a patchy distribution along the
length of the small intestine, whereas the colon
was spared. Consistent with the innate immune
response that has been documented in children
with EED, levels of messenger RNA (mRNA)
transcripts encoding the bactericidal C-type lectins Reg3β and Reg3γ were higher in the duodenums of mice that received the EED collection
than in control mice that received a normal
mouse microbiota (Fig. 2G and Table S11 in
Supplementary Appendix 2; Table S12 shows the
characterization of small-intestine immune responses based on flow cytometry). Levels of
matrix metalloproteinase 8 (MMP8), a protein
with levels that are correlated with the absolute
levels of duodenal bacterial taxa in children with
EED, were significantly higher in serum samples
and along the length of the small intestine of
mice that received the EED collection than in
control mice (Fig. 2H). The observed disruption
of the small intestinal epithelial barrier is consistent with the relatively decreased levels of
mRNA transcripts encoding seven intercellular
tight junction components (e.g., zonula occludens,
claudin 4, and adherens junction formation fac-

nejm.org

July 23, 2020

329

The New England Journal of Medicine
Downloaded from nejm.org at Washington University in St. Louis Becker Library on September 16, 2020. For personal use only. No other uses without permission.
Copyright © 2020 Massachusetts Medical Society. All rights reserved.

The

n e w e ng l a n d j o u r na l

of

m e dic i n e

Eu
th
an

G
av
ag

St
ar

G
av
ag

e

e

td
ie

t

iz e

d

A Design of Study in Gnotobiotic Mice

5.5-Wk-old mouse
0

–2

2

1

3

4

5

6

7

8

9

Day

B Predominant Bacterial Strains

C Duodenum in Mouse with EED Culture Collection

Actinomyces sp.
Aggregatibacter sp.
Bifidobacterium longum
Campylobacter concisus
Enterococcus hirae
Escherichia coli
Fusobacterium nucleatum
Gemella haemolysans
Granulicatella adiacens
Haemophilus influenzae
Haemophilus haemolyticus
Haemophilus parainfluenzae
Neisseria subflava
Prevotella sp.
Staphylococcus aureus
Streptococcus agalactiae
Streptococcus anginosus
Streptococcus dysgalactiae
Streptococcus mutans
Streptococcus parasanguinis
Streptococcus salivarius
Veillonella atypica
Veillonella parvula

100 µm

D Duodenal Villus in Mouse with EED
Culture Collection

E Duodenal Villi in Control Mouse

F Length of Crypts in Duodenum
P<0.001

Crypt Length (µm)

200
180
160
140
120
100
80
60

EED

Control

G Duodenal Expression of Reg3β
and Reg3γ

25 µm

25 µm

Normalized Count
(10−5)

3
2

Q<0.001
1
0

H MMP8 Levels in Serum and Small Intestine

600
400
200

330

EED

Control

105

P=0.005

P=0.002

500

0

Reg3γ

to Spleen

P=0.001
1000

Reg3β

I Bacterial Translocation from Gut
EED
Control

Duodenum Jejunum

n engl j med 383;4

nejm.org

Ileum

CFUs in Spleen

800

0

1500

P=0.01

Tissue MMP8 (pg/mg)

Serum MMP8 (ng/ml)

1000

EED
Control

Q<0.001

P<0.001

104
103
102
101
0

EED

Control

July 23, 2020

The New England Journal of Medicine
Downloaded from nejm.org at Washington University in St. Louis Becker Library on September 16, 2020. For personal use only. No other uses without permission.
Copyright © 2020 Massachusetts Medical Society. All rights reserved.

Duodenal Microbiota in Children with Enteropathy

by recovery of viable E. coli and Enterococcus hirae
in the spleens of mice that received the EED collection but not in the spleens of the controls (Fig
2I). Together, these results support a causal relationship between bacteria cultured from the
duodenums of children with EED and the pathogenesis of enteropathy.

Figure 2 (facing page). Transmission of Enteropathy
to Gnotobiotic Mice by Duodenal Bacteria Obtained
from Study Children with Environmental Enteric
Dysfunction (EED).
Panel A shows the design of the experiment in which
gnotobiotic mice received either a collection of 39 bac‑
terial strains cultured from duodenal samples obtained
from the study children with histopathological evidence
of EED (EED collection) or cecal microbiota of a conven‑
tionally raised mouse (control collection), all adminis‑
tered by oral gavage. Four of the mice that received the
EED collection became moribund 5 days after the sec‑
ond gavage and were euthanized. At this time point,
these mice had lost 20% of their starting body weight,
as compared with a loss of 4.7% for all other mice that
received the EED collection and a loss of 4.9% in the
control group. Panel B shows 23 bacterial strains that
colonized mice in the EED group at a relative level of
more than 0.01% at one or more locations along the in‑
testine. (The biogeographic features of colonization are
provided in Figure S8 in Supplementary Appendix 1.)
The 17 strains belonging to the 14 core taxa that were
detected at the genus level in the duodenums of chil‑
dren with EED are highlighted in purple. Panels C, D,
and E show representative histopathological changes
in the duodenal epithelium and lamina propria of mice
colonized with the EED collection (Panels C and D, re‑
spectively) as compared with control mice (Panel E)
(hematoxylin and eosin staining). (Details regarding
flow cytometric analysis of immune-cell populations
are provided in Table S12 in Supplementary Appendix 2.)
Panel F shows the quantification of crypt length in the
proximal 3 cm of the small intestine in the two groups.
The 10 best-oriented crypts were measured in five mice
in each study group. Each dot represents one measure‑
ment; the horizontal lines denote the mean value. Panel
G shows the differential expression of duodenal Reg3β
and Reg3γ messenger RNAs, as determined by means
of DESeq2 (Q<0.001 for both comparisons after adjust‑
ment for false discovery rate). The numbers in the y axis
are shown at 0.00001 of the actual counts. Panel H shows
levels of matrix metalloproteinase 8 (MMP8) in the se‑
rum and small intestine of the study mice. Panel I shows
the number of colony-forming units (CFUs) of bacteria
translocated from the gut to the spleen in the two study
groups. Each dot represents a splenic homogenate
from an individual mouse in two independent experi‑
ments involving five mice per experiment; the horizon‑
tal line indicates the mean value. All the translocated
bacteria that were recovered from mice that received
the EED collection were identified as Escherichia coli
(lacking the virulence-associated markers of diarrhea‑
genic strains) and Enterococcus hirae. Rare Enterococcus
faecalis, Acinetobacter lwoffii, and A. radioresistens were
recovered from the spleens of the control mice.

Discussion

tor) in the duodenums of mice that received the
EED collection (Table S11 in Supplementary Appendix 2). Moreover, there was bacterial translocation into the systemic circulation, as evidenced
n engl j med 383;4

Our previous work to characterize undernourished Bangladeshi children focused on those
with acute malnutrition and revealed a causal
relationship between the impaired development
of their fecal microbial community and the occurrence of wasting.12,13 The BEED study provided an opportunity to assess the contribution
of the proximal small intestinal microbiota to
stunting in an undernourished Bangladeshi pediatric population who had no benefit from a nutritional intervention. Endoscopy allowed us to
establish a diagnosis of EED on the basis of
characteristic histopathological changes in biopsy
specimens of duodenal mucosa. The lack of correlation between the histopathological scoring
system used here and the length-for-age z score
is consistent with the findings of other studies
that used more elaborate scoring methods.30
Follow-up analyses of biospecimens uncovered a
strong correlation between the absolute levels of
a group of 14 duodenal bacterial taxa and the
degree of stunting in these children and identified duodenal proteins with levels that corresponded to the absolute levels of these bacterial
taxa. Plasma proteins (e.g., REG3A and LCN2)
with levels that correlate with features of the
duodenal proteome (e.g., MMP8) together with
the levels of these 14 duodenal taxa in feces
represent candidate biomarkers of EED. A gnotobiotic mouse model provided support for a
causal relationship between the duodenal microbiota and enteropathy.
Further studies are needed to determine
whether our findings generalize to other populations of children with stunting. The microbial
community of the small intestine remains a
“terra incognita,” and its relationship to the
pathogenesis of gut barrier dysfunction, enteropathy, and stunting has been largely unexplored.
Our results emphasize the need for techniques
for performing imaging and sampling of the
small intestine that are less invasive than those
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currently available in routine practice.31 Ultimately, such methods could allow one limitation
of the current study — the absence of information about the duodenal microbiota of healthy
children — to be surmounted. Comparing the
oral microbiota of children with EED with those
of healthy children may also be informative. The
possibility that a healthy child’s duodenal or
even fecal microbiota may contain factors that
ameliorate or prevent the development of EED
has therapeutic implications.
The findings from our gnotobiotic mouse
model, which provided support for a causal relationship between the microbiota in the proximal
small intestine and the pathological features of
EED, suggest new opportunities for investigation. These avenues include further dissection of
interactions between members of the collection
of bacterial strains associated with enteropathy
and defining factors that negatively affect their
fitness, a goal that may be facilitated by in silico
metabolic reconstructions of their nutrient requirements (Fig. S7 and Table 3 in Supplementary Appendix 3). Exploration of the mechanisms by which members of the small intestinal
microbiota affect the mediators of linear growth
of young children may result in the development
of new therapeutic approaches for stunting.
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